ZNF780A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.49669959653909E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.17949999999911E-05 |
Normal-vs-Stage2 |
6.832400E-04 |
Normal-vs-Stage3 |
3.71259689657677E-11 |
Normal-vs-Stage4 |
3.26699778341322E-11 |
Stage1-vs-Stage2 |
4.740800E-01 |
Stage1-vs-Stage3 |
8.62259999956372E-07 |
Stage1-vs-Stage4 |
1.11499999999598E-06 |
Stage2-vs-Stage3 |
6.191900E-02 |
Stage2-vs-Stage4 |
4.558000E-02 |
Stage3-vs-Stage4 |
7.764600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.66620051089694E-10 |
Normal-vs-AfricanAmerican |
3.036800E-04 |
Normal-vs-Asian |
6.234000E-01 |
Caucasian-vs-AfricanAmerican |
3.616200E-01 |
Caucasian-vs-Asian |
8.387900E-02 |
AfricanAmerican-vs-Asian |
2.133800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.65420002327255E-09 |
Normal-vs-Female |
1.96170002464413E-09 |
Male-vs-Female |
5.654800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.787500E-04 |
Normal-vs-Age(41-60Yrs) |
5.57389999999991E-05 |
Normal-vs-Age(61-80Yrs) |
1.63790003782083E-09 |
Normal-vs-Age(81-100Yrs) |
8.11189999949669E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.579600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.405200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.210440E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.297980E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.080080E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.369900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.762200E-01 |
Normal-vs-Grade 2 |
7.53430000000055E-05 |
Normal-vs-Grade 3 |
5.79229997299535E-09 |
Normal-vs-Grade 4 |
2.91766610871491E-13 |
Grade 1-vs-Grade 2 |
1.548220E-01 |
Grade 1-vs-Grade 3 |
2.758000E-03 |
Grade 1-vs-Grade 4 |
2.28660000001213E-06 |
Grade 2-vs-Grade 3 |
3.936300E-03 |
Grade 2-vs-Grade 4 |
2.39699999848852E-08 |
Grade 3-vs-Grade 4 |
1.181890E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.022400E-04 |
Normal-vs-ccB subtype |
8.31750224250527E-11 |
ccA subtype-vs-ccB subtype |
6.000700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.54670001648338E-09 |
Normal-vs-N1 |
4.952300E-04 |
N0-vs-N1 |
3.018800E-01 |
|
|